New US patent related to Oasmia Pharmaceutical’s nanotechnology platform XR17 has been granted
New US patent related to Oasmia Pharmaceutical’s nanotechnology platform XR17 has been granted P&T Community Full coverage
PATENT NEWS
-
In: PATENT NEWS
-
In: PATENT NEWS
Justices Won’t Hear Challenge To Fed. Circ. Drug Patent Test
Justices Won’t Hear Challenge To Fed. Circ. Drug Patent Test Law360 Full coverage
-
In: PATENT NEWS
Justices Won’t Examine ‘Multiple Proceedings’ Patent Rule
Justices Won’t Examine ‘Multiple Proceedings’ Patent Rule Law360 Full coverage
-
In: PATENT NEWS
Prosecution Strategies for Avoiding Patent Eligibility Rejections for Diagnostics
Prosecution Strategies for Avoiding Patent Eligibility Rejections for Diagnostics The National Law Review Mixed Result in Finjan Patent Appeal Bloomberg Law Massive SportBrain Patent Litigation Officially Ends Law.com Full coverage
-
In: PATENT NEWS
Disney Files Patent for Retractable Internally-Illuminated Lightsaber
Disney Files Patent for Retractable Internally-Illuminated Lightsaber wdwnt.com Full coverage
-
In: PATENT NEWS
Patent and trademark – Infringement
Patent and trademark – Infringement Massachusetts Lawyers Weekly Full coverage
-
In: PATENT NEWS
Nasdaq Wants Fish & Richardson DQ’d From Patent Fight
Nasdaq Wants Fish & Richardson DQ’d From Patent Fight Law360 Full coverage
-
In: PATENT NEWS
Global Patent Prosecution Newsletter – November 2018: Blockchain-ing Alice?
Global Patent Prosecution Newsletter – November 2018: Blockchain-ing Alice? JD Supra (press release) Full coverage
-
In: PATENT NEWS
Patent-protected drugs comprise 66% of brand drug spending, BCBS says
Patent-protected drugs comprise 66% of brand drug spending, BCBS says Becker’s Hospital Review Full coverage
-
In: PATENT NEWS
A Quick Guide to DIY Patent Searching
A Quick Guide to DIY Patent Searching Lexology Full coverage